Hero Technologies Inc. HENC OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

25/100

1/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Hero Technologies Inc. (HENC) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 23/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

25/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

0/100

→ Income

✓

GROWTH

100/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — HENC

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2013	$0.00	$0.00	$-542K	-
2014	$0.00	$0.00	$323.84K	-
2015	$-0.02	$0.00	$-1.72M	-
2016	$0.00	$0.00	$-90.76K	-
2017	$0.00	$0.00	$-132K	-
2018	$0.00	$0.00	$-34.34K	-
2019	$-0.09	$0.00	$-12.88M	-
2020	$-0.04	$197.00	$-5.96M	-3024365.5%
2021	$-0.01	$1.53K	$-3.42M	-224262.3%
2022	$0.00	$0.00	$-541.58K	-